State Of Wisconsin Investment Board Denali Therapeutics Inc. Transaction History
State Of Wisconsin Investment Board
- $36.9 Billion
- Q4 2024
A detailed history of State Of Wisconsin Investment Board transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 93,094 shares of DNLI stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,094
Previous 81,451
14.29%
Holding current value
$1.93 Million
Previous $2.37 Million
20.03%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding DNLI
# of Institutions
241Shares Held
121MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$273 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$255 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$249 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$204 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$114 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.78B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...